Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Allievex
P.O. Box 1056
Marblehead, MA 01945
Phone: 617-642-8677
https://www.allievex.com/

Allievex, a clinicalstage biotechnology company founded by Pappas Capital, is developing novel therapies for the treatment of rare pediatric neurodegenerative diseases. Allievex's lead product candidate is tralesinidase alfa, an investigational enzyme replacement therapy using a novel fusion of recombinant human alphaNacetyglucosaminidase (NAGLU) with a peptide derived from insulinlike growth factor 2 (IGF2) for the treatment of children with Sanfilippo syndrome type B or mucopolysaccharidosis IIIB (MPS IIIB).

Key Contact
Name
Thomas P. Mathers
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
10/23/19 undisclosed Series A Novo Holdings
Pappas Capital
undisclosed